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Tumorigenesisrane L6 family member 5 (TM4SF5), a homolog of tumor antigen L6, was
previously shown to be highly expressed in diverse tumors. We recently found that human hepatocarcinoma
tissues also overexpressed TM4SF5 protein, in comparison to normal liver tissues. We also found that tiarellic
acid (TA) caused cell detachment-related apoptosis in cells expressing endogenous or stably-overexpressing
TM4SF5. When cells expressing TM4SF5 were treated with TA, we observed reduced phosphorylation of focal
adhesion kinase, paxillin, and p130Cas, but not c-Src. TA treatment also caused focal adhesion loss and
reduced cell adhesion, and increased the numbers of ﬂoating cells and apoptotic cells. These effects were
blocked by overexpression of focal adhesion molecules, suggesting that treatment with TA mediates anoikis
of TM4SF5-expressing cells. However, TM4SF5-null cells were not affected by TA, indicating that these effects
occur speciﬁcally in TM4SF5-positive cells. TA administration reduced tumor formation in nude mice injected
with TM4SF5-expressing cells, presumably through increased apoptosis in TM4SF5-positive tumors. These
observations indicate that TM4SF5-positive tumorigenesis can be inhibited by TA via induction of cell
detachment-related apoptosis, and suggest that TA may be developed as a putative therapeutic reagent
against TM4SF5-positive tumorigenesis.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIntegrin-mediated cell adhesion triggers diverse intracellular
signal transductions that regulate the activities and localizations of
diverse signaling molecules, and consequently cell behaviors [1–3].
When integrins interact extracellularly to extracellular matrix (ECM)
at focal adhesions, intracellular cytoplasmic tails of integrin subunits
recruit diverse focal adhesion molecules including FAK, paxillin,
p130Cas, c-Src, and etc [4]. Since the integrins at the focal adhesions
are linked to actin ﬁlaments through protein complexes at their
cytoplasmic tails [5,6], inefﬁcient assembly and activation of focal
adhesion molecules and/or abnormal reorganization of actin ﬁla-
ments can cause cells to be round-shaped with concomitant loss of
focal adhesions, leading to consequent detachment of cells from and
disruption of the epithelial integrity on basement membrane [7].
However, cancer cells due to multiple mutations and genomic in-
stabilities may be allowed to disseminate from a primary tumor by, College of Medicine, Seoul
l 110-799, Korea. Tel.: +82 2
l rights reserved.abnormal alteration of cell–ECMinteractions andcell–cell contacts [8]. In
the steps of disruption of basement membrane and migration/invasion
through stromal region for cancer metastasis, integrin-mediated adhe-
sionof cancer cells to ECMmaycritically affect themetastatic potential of
cells [9–11]. Amongdisseminated cancer cells, only cells survived anoikis
may travel to distant sites via blood and lymphoid vessels, andeventually
attach to a site and proliferate as metastatic tumors [12]. Therefore,
it would be useful to ﬁnd reagent(s) to cause apoptosis or anoikis
of tumorigenic cells without any effects on normal cells, when anti-
tumorigenic or metastatic reagents are being screened.
TM4SF5 (also known as L6H) is a homolog of tumor-associated
antigen L6 (TM4SF1) and forms a four-transmembrane L6 superfamily
with L6, IL-TMP, and L6D [13]. TM4SF5 is highly expressed in diverse
tumor types [14,15]. Tetraspanins (also known as TM4SF or tetraspans)
are a group of hydrophobic proteins of 25–50 kDa with four trans-
membrane domains, two extracellular loops, and two short cytoplasmic
tails [16]. The extracellular loop 2 (EC2) of genuine tetraspanins has a
variable region thatmediates speciﬁc protein–protein interactions and a
conserved region thatmediates homodimerization [16]. The EC2 loop of
TM4SF5, amemberof a four-transmembrane L6 superfamily, however, is
relatively divergent and has 2 cysteine residues, whereas the EC2 of
genuine tetraspanins has a variable region and conserved 4 cysteines for
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domains of tetraspanins are suggested to be responsible for intra- and
inter-molecular interactions during biosynthesis and organizing the
‘tetraspanin-web’on cell surface [16]. Tetraspanins formcomplexeswithintegrins to collaboratively perform their roles in cell adhesion, pro-
liferation, and motility [17,18]. It was previously shown that KAI1/CD82
expression in Du145 prostate cells down-regulated p130Cas leading to
suppression of cell motility, and overexpression of p130Cas in the cells
Fig. 2. TA-mediated growth inhibition of endogenously TM4SF5-expressing cells.
(A) Expression levels of endogenous TM4SF5 mRNA or protein in diverse cell lines were
analyzed via RT-PCR and Western blot. Control GAPDH levels during RT-PCR were
observed to be quite similar in comparisons between different cell lines. (B) To examine
TA-mediated viabilities of diverse cell lines with or without endogenous TM4SF5, cells
were separately seeded in triplicate (at an equal cell number) into 24well culture plates.
One day later, DMSO or TA at different concentrations were treated to cells for the
indicated periods, before counting of viable cells, as in Fig. 1D. Data shown represent
three independent experiments.
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TM4SF5 overexpression in hepatocytes caused actin reorganization
through regulation of FAK andRhoA activity, leading to losses of cell–cell
adhesion and contact inhibition [20].Wehave also observed that ectopic
TM4SF5 inﬁbroblastswas shown to interactwith integrinα2 to regulate
focal adhesion turnover and actin reorganization [21]. Therefore, it is
likely that TM4SF5may cross-talk with the integrins to regulate cellular
functions.
While trying to identify reagents to regulate TM4SF5-mediated cell
proliferation, we found that tiarellic acid [TA, [22]] could cause cell
detachment-related death in a TM4SF5 expression-dependent man-
ner. TA treatment decreased phosphorylation of focal adhesion
molecule and cell adhesion, enhanced apoptosis of TM4SF5-expres-
sing (but not -null) cells, and interfered with TM4SF5-mediated tumor
formation in nude mice. Altogether, these observations suggest that
TA may be a putative anti-tumorigenic reagent speciﬁcally against
TM4SF5-positive tumors.
2. Materials and methods
2.1. Cells
Pooled stable clones (control SNU449Cp and TM4SF5-expressing SNU449Tp cell
clones) and single cell-driven stable clones (TM4SF5-expressing SNU449T16) were
prepared by infecting SNU449 hepatocytes (Korean Cell Bank, Korea) with retrovirus for
empty pLNCX or pLNCX with TM4SF5 [20]. Stable and TM4SF5-null parental cells were
maintained in RPMI-1640/10% FBS/0.25 μg/ml gentamycin (Calbiochem, San Diego, CA)
with or without 200 μg/ml G418 (A.G. Scientiﬁc Inc., San Diego, CA), respectively, at
37 °C and 5% CO2. Other cell lines with or without endogenous TM4SF5 (Korean Cell
Bank) were maintained in either DMEM-H or RPMI-1640 media with 10% FBS (JBI Inc.,
Daegu, Korea).
2.2. Preparation of tiarellic acid (TA)
Whole plants of Tiarella polyphylla collected from Ullung island (Kyungsang-Bukdo,
Korea) were extracted with MeOH, concentrated, suspended in water, partitioned
successfully with EtOAc prior to column chromatography on silica gel eluting with
hexane followed by hexane-EtOAc mixtures of increasing polarity and ﬁnally with
CHCl3–MeOH (1:1) mixture, as previously explained [23]. HPLC (MeOH 58%+0.2% TFA
42%) of TA (0.1 μg/μl, 3,23-dihydroxy-20(29)-lupen-27-oic acid, [22]) was performed
using Finnigan Surveyor HPLC system with column of Perfectsil Target ODS-3.
2.3. Cell lysate preparation and Western blots
Whole cell lysates from cells under diverse experimental conditions were prepared,
as described previously [21]. In cases, cells were electroporated (at 950 μF and 250 V)
with control GFP, wildtype FAK, paxillin, or p130Cas cDNA plasmid. One day after
electroporation, cells were treated with TA (20 μM) for the indicated periods. Cells
cultured normally or treated with TA at different concentrations for the indicated
periods were harvested using RIPA buffer [21]. Control or tumor tissues from nude mice
were frozen immediately after surgery using liquid N2. Tissues was homogenized in the
liquid N2 and extracted using 0.1% SDS containing RIPA buffer, prior to spin (13000 ×g,
30 min) at 4 °C. Standard Western blots of lysates were performed by using antibody
against phospho-Y397, Y407, Y577, Y861, and Y925FAK (Invitrogen, Carlsbad, CA), Bcl-2, Bax,
phospho-Y416Src, c-Src, p15INK4B, p16INK4A (Santa Cruz Biotech., Santa Cruz, CA), FAK,
p130Cas, paxillin, phospho-Y118paxillin, active caspase-3 (BD Bioscience, San Jose, CA),
α-tubulin (Sigma, St Louis, MO), phospho-S473, phospho-T308Akt, Akt (Cell Signaling
Tech., Danvers, MA), or TM4SF5 (homemade).
2.4. Anti-TM4SF5
Rabbit polyclonal antibody was produced against amino acid residues from 120 to
132 of TM4SF5 (NM-003963) conjugated with keyhole limpet hemocyanin (KLH, A &
Pep Inc., Yeongi-Gun, Korea). The sera were further puriﬁed by afﬁnity chromatography
using protein A/G-sepharose (Invitrogen).Fig. 1. TA causes detachment-related death of ectopically TM4SF5-expressing cells. (A) Who
were immunoblotted for TM4SF5 and α-tubulin. (B) Parental SNU449 and stable control SN
expression [21] were conﬁrmed for TM4SF5 expression. Whole cell extracts from subconﬂue
and used in immunoblots for the indicated molecules. (C) Chemical structure (left) and HPL
well plate at 1×105 cells/well, cells were treated with DMSO or TA at different concentratio
counted in triplicate using a hemocytometer (D). Alternatively, total ﬂoating cells at the indic
seeded and 24 h later treated with 20 μM TA for the indicated periods (F) or 24 h (G). (F) W
molecules. (G) DNA content analysis after propidium iodide staining for 30minwas performe
DNA contents was included in each histogram. Data shown represent three independent ex2.5. Immunoﬂuorescence microscopy
Cells were treated with DMSO or 20 μM TA for 24 h before being replated on
ﬁbronectin (10 μg/ml)-precoated coverslips for an additional 2 h incubation in the
presence of DMSO or 20 μM TA. Fluorescent staining was performed, as described
previously, for analysis by ﬂuorescent microscopy (BX51, Olympus, Japan) [21].
2.6. Mouse and tumor xenografts
Four- or ﬁve-week-old female nude (BALB/cAnNCrjBgi-nu, Orient Co. Ltd.,
Seongnam, Korea) mice were housed and handled, according to the procedures in
the Seoul National University Laboratory Animal Maintenance Manual and IRB
approval. Mice were injected subcutaneously in a ﬂank with 5×106 of viable
SNU449Cp, SNU449T16, or CT26 murine colon carcinoma cells. Tumor volumes
were measured with a caliper and calculated using the formula: Volume= (a× b2) / 2,
where a was the width at the widest point of the tumor and b was the maximalle cell extracts from normal (N) or tumor (T) liver tissues from liver carcinoma patients
U449Cp cells without or stable SNU449Tp and SNU449T16 cells with ectopic TM4SF5
nt cells (upper) or cells treated with or without 20 μM TA for 24 h (lower) were prepared
C chromatogram of tiarellic acid (TA). (D and E) One day after cells were seeded into 24
ns for 1, 2, or 3 days. After incubation, viable cells after staining with trypan blue were
ated conditions were collected by spin-down and then counted (E). (F and G) Cells were
hole cell lysates were prepared and used in standard Western blots for the indicated
d, as explained previously [26]. The percentage of the populationwith apoptotic sub-G1
periments.
1635S. Choi et al. / Biochimica et Biophysica Acta 1783 (2008) 1632–1641width perpendicular to a. Intraperitoneal (IP) injection of TA (at 3 or 30 mg/kg
body weight in 5% DMSO) to mice with TM4SF5-mediated tumors (~200 mm3
of calculated tumor volume) was performed every other day for the indicated
periods.
2.7. Human liver tissue sample
Normal and tumor liver tissues were obtained from patients in the Kyungpook
National University Hospital (Daegu, Korea) from March to April, 2007 with informedFig. 3. TA causes inactivation of and complex disassembly among focal adhesion molecules in a
about 40% density. One day after, cells were treated with DMSO or TA at diverse concentration
Western blots for the indicatedmolecules. (D) An equal amount of proteins for each conditionw
reveal p130Cas phosphorylation, or anti-FAK or -paxillin to determine complex formation amoconsent and IRB approval. Clinical and biological information was available for the
tissue samples.
2.8. Tumor histology
Tumor tissues were removed about 6weeks after injecting SNU449T16 cells or after
TA IP injection for one month, ﬁxed with formalin, and embedded in parafﬁn. Serial
sections (6 μm thick) cut from each parafﬁn block were stained with anti-active
caspase-3, prior to visualization by ﬂuorescent microscopy (BX51, Olympus, Japan).dose- and time-dependent manner. (A to E) Cells were seeded to 60mm culture dishes at
s for the indicated periods. After incubation, lysates were prepared and used in standard
as immunoprecipitatedwith anti-p130Cas, before immunoblots with anti-phospho-Tyr to
ng the molecules. Data shown represent three independent experiments.
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Cells were seeded into 24well culture plates at 1×105 cells/well. One day later, cells
in triplicate were treated with TA at different concentrations for the indicated periods.
After incubation, viable cells after trypan blue staining or total ﬂoating cells were
counted.
2.10. Immunoprecipitation
Cell lysates were immunoprecipitated with p130Cas, integrin α5, or FAK antibody.
The p130Cas immunoprecipitates were immunoblotted with anti-phospho-Tyr, FAK, or
paxillin, whereas the FAK or integrin α5 immunoprecipitates were immunoblotted for
integrin α5 or pY397FAK, respectively, as explained previously [24].
2.11. Cell adhesion assay
Cells treated with DMSO or 20 μM TA for 24 h were trypsinized and suspended in
RPMI-1640 containing 1% BSA. The cells were then processed for assay of adhesion on
ﬁbronectin for 1 h, as explained previously [25].
2.12. DNA content assay
The DNA content analysis via propidium iodide staining was performed for cells
with or without TA treatment, or for cells transfectedwith GFP, FAK, paxillin, or p130Cas
wildtype with or without TA treatment (20 μM for 24 h), as previously explained [26].
2.13. Statistical analysis
The Student's t-test was performed for comparison of mean values to see if the
difference is signiﬁcant. p values ≤0.05 were considered signiﬁcant.Fig. 4. TA causes detachment of TM4SF5-expressing, but not -null, cells via loss of focal adhe
being replated on ﬁbronectin (10 μg/ml)-precoated coverslips. Replated cells were then incub
pY397FAK or pY118paxillin (A), or actin staining using phalloidin-conjugated Rhodamine (C). (
with anti-FAK or -integrin α5 (P1D6 clone). Immunoprecipitates or lysates were immunobl
reseeded, and 1 day later treated with DMSO or TA (20 μM) for 24 h. After incubation, cells w
each condition were evaluated for adhesion (for 1 h) onto ﬁbronectin (10 μg/ml), as expla
parental SNU449 (P) cells (at 100%) were calculated from measurements in triplicate, and m
(pN0.05) and signiﬁcance (p≤0.05), respectively. Data shown represent three independent3. Results
3.1. TA treatment results in cell detachment-related death of
TM4SF5-expressing cells
While investigating to seewhether TM4SF5mightbeassociatedwith
tumorigenesis, we found that TM4SF5 was signiﬁcantly overexpressed
in liver tumor tissue obtained from hepatocarcinoma patients, com-
pared to normal liver tissue (Fig. 1A). To identify reagents that have an
effect on cells expressing TM4SF5, we screened diverse natural product-
driven chemicals to observe selective cytotoxic effects against TM4SF5-
expressing cells. We used TM4SF5-negative parental SNU449 and con-
trol stable SNU449Cp hepatocytes and TM4SF5-positive SNU449Tp and
SNU449T16 stable cells (Fig. 1B, upper) to examine cytotoxic sensitivity
to a variety of lupane-derived triterpenoid plant compounds. Among
the compoundswe tested, tiarellic acid (TA, Fig.1C) was found to inhibit
growth of TM4SF5-expressing cells (Fig. 1D), although TA treatment did
not change TM4SF5 expression levels (Fig. 1B, lower). TM4SF5-ex-
pressing SNU449Tp cells treated with TA showed cell death accom-
panied by rounded cell morphology (data not shown), whereas
TM4SF5-null SNU449Cp cells were not affected by TA treatment.
Treatment with 20 μM TA even for 1 day decreased the number of
TM4SF5-expressing cells (Fig. 1D). These observations indicate that TA
might target other molecules(s) than TM4SF5 itself in the initiation of
cell death.sion and stress ﬁber. (A to C) Cells were treated with DMSO or 20 μM TA for 24 h, before
ated for 2 h in the presence of DMSO or 20 μMTA, before immunoﬂuorescent staining for
B) Lysates were prepared from subconﬂuent SNU449 T16 cells for immunoprecipitation
otted for the indicated molecules. (D) Parental (P) and stable SNU449 cell clones were
ere detached and resuspended into RPMI1640 with 1% BSA. An equal number of cells for
ined in Materials and methods. Relative adhesions compared to basal adhesion of the
ean±standard deviation values were graphed. ⁎ and ⁎⁎ indicate statistical insigniﬁcance
experiments.
Fig. 4 (continued).
Fig. 5. Overexpression of focal adhesion molecules blocked the TA-mediated effects.
(A and B) SNU449T16 cells were electroporated with cDNA plasmid for GFP, FAK,
paxillin, or p130Cas wildtype, as explained in Materials and methods. (A) One day after
electroporation, cells were treated with 20 μMTA for different periods. After incubation,
whole cell lysates were prepared, normalized, and used in standard Western blots for
the indicated molecules. Note that expression of focal adhesion molecules, but not of
control GFP, resulted in the blockade of TA-mediated signaling inactivation and caspase-
3 activation. (B) One day after electroporation, cells were treated with DMSO or 20 μM
TA for 24 h. After incubation, cells were collected and stained with propidium iodide for
DNA content analysis, as above. Data shown represent three independent experiments.
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after DMSO or TA treatment, we found that TA treatment increased the
number of ﬂoating SNU449Tp cells, but not of control SNU449Cp cells
(Fig. 1E). TA treatment of SNU449T16 cells also resulted in Akt in-
activation, Bcl-2 reduction, Bax induction, and caspase-3 activation,whereas no effects were seen in control SNU449Cp cells (Fig. 1F). In
addition, analysis of cellular DNA content after treatment with 20 μM
TA for 24 h resulted in signiﬁcant sub-G1 populations of SNU449Tp
and T16, but not of control SNU449Cp cells (Fig. 1G). The TA-mediated
apoptosis rate was less than the overall loss in viability (Fig. 1D),
presumably due to different sensitivities of experimental methods
and/or technical difﬁculties to collect all apoptotic bodies during
sample preparation for FACS analysis. Therefore, these observations
suggest that TA causes cell detachment-related death of TM4SF5-
expressing cells.
We next evaluated whether TA treatment of cells overexpressing
TM4SF5 was valid for cells that endogenously express TM4SF5. We
examined the effects of TA treatment at 5 or 20 μM on cell growth and
survival using diverse cell lines with or without endogenous TM4SF5
(Fig. 2A). Growth of TM4SF5-null cells (including Hek293 and COS7
ﬁbroblast, MDA-MB453 breast, SNU638 and SNU668 stomach, and
SNU398 liver epithelial cells) was not affected by TA treatment;
although Hek293 cells showed a slight retard of growth rate after TA
treatment, they still increased in cell number (Fig. 2B left and data
not shown). However, cells with endogenous TM4SF5 expression
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suppression after TA treatment, leading to the eventual decrease in cell
number (i.e., cell death) over time (Fig. 2B, right).
3.2. TA-mediated inhibition of focal adhesion molecule activation and
focal adhesion formation
To examine the molecular basis for TA-mediated cell detachment
and death, we analyzed signaling molecules known to participate in
focal adhesion upon integrin-mediated cell adhesion. SNU449 stable
cell lines were treatedwith TA in a dose- and time-dependentmanner.
SNU449Cp or SNU449T16 cells were treated with varying TA con-
centrations for 24 h prior to immunoblot analysis. SNU449T16 cells
treated with 20 μMTA showed reduced FAK and paxillin phosphoryla-
tion and p130Cas protein levels, whereas SNU449Cp cells were not
affected (Fig. 3A). TA treatment decreased FAK and paxillin phosphor-
ylation and p130Cas protein levels in a time-dependent manner
in SNU449T16, but not in SNU440Cp cells (Fig. 3B). The TM4SF5-
dependent inhibitory effects of TA on focal adhesion molecule phos-
phorylation and activity were observed in both SNU449Tp and T16 cell
lines (Fig. 3C). In addition, TA treatment decreased p130Cas phosphor-
ylation and the physical association among FAK, p130Cas, and paxillin
(Fig. 3D). These observations indicate that TA treatment affected
phosphorylation and complex formation of focal adhesion molecules
only in TM4SF5-expressing cells. In addition, TA-mediated effects on
focal adhesion molecule phosphorylation were examined in cells that
express endogenous TM4SF5 and in null cell lines. The inhibitory
effects of TA treatment were observed also in cells endogenously
expressing, but not lacking, TM4SF5 (Fig. 3E). Since TA suppressed focal
adhesion molecule phosphorylation and complex formation, focal
adhesion formationwould likely be affected by TA treatment. We thus
analyzed focal adhesion formation in TA-treated and -untreated
cells by performing immunostaining for Tyr397-phosphorylated
FAK (pY397FAK) or Tyr118-phosphorylated paxillin (pY118paxillin).
Although TA treatment did not affect focal adhesion formation in
TM4SF5-null cells, focal adhesions in TM4SF5-expressing cells were
lost after TA treatment (Fig. 4A). TA-mediated loss of focal adhesions
appeared to involve a dissociation between integrin α5 and pY397FAK
in TM4SF5-expressing cells (Fig. 4B), being consistent with integrin-
mediated recruitment of focal adhesion molecules such as pY397FAK
[21]. Furthermore, since focal adhesions are linked to each other via
stress ﬁbers [27], we also stained actin in TA-treated and -untreated
cells. Cells expressing TM4SF5 showed abnormal actin organization
with insigniﬁcant stress ﬁbers after TA treatment, whereas TM4SF5-
null cells did not (Fig. 4C). The loss of focal adhesions and stress ﬁber
formation in TA-treated, TM4SF5-expressing cells could contribute to
the observed cell rounding after TA treatment (data not shown).
Since TA treatment caused inactivation and disassembly of focal
adhesion molecules, possibly contributing to a rounded morphology,
and resulting in detachment-related apoptosis of TM4SF5-expressing
cells, we next wondered whether TA treatment affected cellular ad-
hesion. Cells treated with 20 μM TA for 24 h were collected and
reseeded on ﬁbronectin-precoated dishes for 1 h before determina-
tion of the degree of adhesion. Adhesion of TM4SF5-null SNU449 and
SNU449Cp cells was not affected by TA treatment, whereas TM4SF5-Fig. 6. TA interferes with TM4SF5-mediated tumor formation in nude mice. (A and D) SN
subcutaneously into nude mice (5×106 cells/mouse). Normal maintenance was perform
MaintenanceManual. Signiﬁcant tumorigenesis in SNU449T16-injectedmice (n=7) or CT26-
did not form any signiﬁcant tumors, and thus no graphic presentation for SNU449Cp was in
every other day after the TM4SF5-mediated tumors had been about 200 mm3. Tumor volum
were plotted as mean±standard deviation. (B) Extracts from control tissue or tumor tissue
molecules, as explained in Materials and methods. (C) Immunohistochemical staining of t
administration was performed for active caspase-3, as explained in Materials and meth
positive for active caspase-3 in the middle of the tumor mass. (Western blot insert of D) S
TM4SF5 or α-tubulin to see no endogenous level of TM4SF5 in CT26 cells. Data shown reprexpressing SNU449Tp and T16 cells pretreated with TA showed
signiﬁcantly reduced adhesions, compared to the control vehicle-
treated cells (Fig. 4D). This observation appeared to be consistent with
the observed TA-mediated detachment and death of TM4SF5-positive
cells in Fig. 1.
3.3. Overexpression of focal adhesion molecules blocked the
TA-mediated effects
We next evaluated whether overexpression of FAK, paxillin, or
p130Cas would block the effects of TA treatment, assuming that their
expression to higher levels would result in more focal adhesion
formation and activation. To explore this, we introduced each cDNA
into SNU449T16 cells via electroporation. Due to transient over-
expression of FAK, paxillin, or p130Cas, TA treatment was performed
1 day after electroporation. TA treatment of SNU449T16 cells in-
troduced with control plasmid (for GFP) showed time-dependent
inactivation of focal adhesion molecules and activation of caspase-3,
supporting our hypothesis of TA-mediated apoptosis. However,
SNU449T16 cells introduced with wildtype FAK, paxillin, or p130Cas
resulted in certain degrees of blocking TA-mediated effects (Fig. 5A).
Furthermore, overexpression of the focal adhesion molecules also
blocked TA-mediated increases in the sub-G1 population (Fig. 5B).
Therefore, the TA-mediated effects on TM4SF5-expressing cells
could be overcome to a certain degree by overexpression of focal
adhesion molecules.
3.4. TA interfered with TM4SF5-mediated tumor formation in nude mice
We next evaluated whether TM4SF5 mediated tumor formation
in nude mice and whether TA administration might interfere with
tumorigenesis. Nude mice injected with TM4SF5-expressing
SNU449T16 cells formed signiﬁcant tumors, whereas injection with
TM4SF5-null SNU449Cp cells did not form tumors (Fig. 6A). When TA
was given intraperitoneally every other day for 30 days to mice
with established tumors (~200 mm3 of calculated tumor volume),
TM4SF5-mediated tumor formation was decreased. Administration
of TA at 3 or 30 mg/kg body weight decreased the tumor volumes to
46.0% or 22.1%, respectively, while body weight increased normally,
indicating no signiﬁcant toxic side effects (Fig. 6A). Although we
did not determine whether TA caused any local side effects in the TA-
treated mice such as blood pressure decrease and mucosal damage,
an intraperitoneal administration of TA at 2 g/kg did not cause
any abnormal behaviors or abnormalities in organ structures until
sacriﬁce after 2 weeks (S-R Oh and H-K Lee, unpublished obser-
vation). Western blot analysis using control tissue around the
spot injected with control SNU449Cp cells and tumor tissue of
SNU449Tp-injected mice revealed that TM4SF5-mediated tumor
tissue showed Akt activation and caspase-3 inactivation, indicating
signaling activities for tumor formation (Fig. 6B, lanes 1 to 2).
However, TA administration decreased Akt activation, increased
p15INK4B or p16INK4A cyclin-dependent kinase inhibitor (CKI) levels,
and enhanced caspase-3 activation, indicating that TA caused growth
inhibition and apoptosis in the TM4SF5-mediated tumors (Fig. 6B,
lanes 2 to 4). Immunohistochemical staining for active caspase-3 wasU449Cp or SNU449T16 (A) or CT26 murine colon carcinoma (D) cells were injected
ed according to the procedures in the Seoul National University Laboratory Animal
injectedmice (n=7) was observed. However, SNU449Cp control cell-injectedmice (n=7)
cluded (A). IP injection of TA at 3 (n=7) or 30 mg/kg body weight (n=7) was performed
e values calculated and body weights measured, as explained in Materials and methods,
of SNU449T16 cell-injected mice were prepared and immunoblotted for the indicated
umors from SNU449T16 cell-injected mice with DMSO or TA (30 mg/kg in 5% DMSO)
ods. Note that TM4SF5-tissue section with TA administration shows apoptotic cells
ubconﬂuent SNU449T16 (T16) and CT26 cells were harvested and immunoblotted for
esent three independent experiments.
1640 S. Choi et al. / Biochimica et Biophysica Acta 1783 (2008) 1632–1641positive in TM4SF5-mediated tumor tissue obtained from mice that
had been treated with TA, but not from mice treated with vehicle
DMSO (Fig. 6C). Since we observed that TM4SF5-positive cells were
undergoing apoptosis after TA treatment, it may be likely that doses
higher than 30 mg/kg may cause cytostatic effects leading to dor-
mancy of TM4SF5-mediated tumors in mice. On the other hand, nude
mice injected with TM4SF5-negative CT26 murine colon carcinoma
cells followed by TA treatment (30 mg/kg body weight) did not result
in decreased tumor formation (Fig. 6D). Therefore, TA speciﬁcally
interfered with TM4SF5-mediated tumor formation in nude mice,
presumably by enhancing apoptosis. These results suggest that TA
might be developed further as a potential therapeutic reagent for
TM4SF5-positive tumors.
4. Discussion
This study provides evidence that TM4SF5-positive cell growth and
tumor formation in nude mice can be negatively regulated by tiarellic
acid (TA), a component puriﬁed from T. polyphylla [22]. TA treatment
resulted in the cell detachment-related death of TM4SF5-expressing
cells, but not null cells; TA inhibited activation of and complex for-
mation between focal adhesion molecules, blocked formation of focal
adhesions, decreased adhesion property, and increased death in cells
ectopically and endogenously expressing TM4SF5. TM4SF5 mRNA
is overexpressed in diverse tumor types [14,15] and we show in this
study that TM4SF5 protein is overexpressed in human hepatocarci-
noma tissue. Therefore, the signiﬁcance of TA-mediated apoptosis in
TM4SF5-expressing cells can be important for therapeutic purposes
against TM4SF5-positive cancers, although the precise target of TA
during the TA-mediated detachment-related death of TM4SF5-
expressing cells is unknown.
Other genuine tetraspanins form tetraspanin-web structures by
interacting with integrins to collaboratively perform their functions in
cell adhesion, proliferation, and motility [17,18,28]. We have previously
reported that TM4SF5 regulates focal adhesion turnover and actin
reorganization inﬁbroblasts, dependingon the associationwith integrin
α2 [21]. In addition, TM4SF5 in hepatocytes was shown to modulate
cellular morphology via regulation of FAK and RhoA activities [20].
TM4SF5 may thus modulate architectural integrity and/or signaling
activity ofmembrane proteins, including integrins and othermembrane
receptors. TA was previously shown to reduce MMP-1 expression and
induce type 1-procollagen expression after ultraviolet irradiation of
primary human skin ﬁbroblasts [23], although it is not knownwhether
the primary skin ﬁbroblasts express TM4SF5 or not. Therefore, TA
appears to regulate the behaviors of TM4SF5-expressing cells by
inﬂuencing cell adhesion-related molecules. TA treatment of Hek293
cells lacking TM4SF5 resulted in a slight growth retard, although they
still were divided to positively increase cell numbers, whereas other
TM4SF5-negative cell lines were not inﬂuenced (Fig. 2B). Therefore, it
cannot be ruled out that Hek293 cells may express a TM4SF5-related
protein, such as L6 (TM4SF1), IL-TMP, and L6D, or that TAmay also have
alternative targets involved in Hek293 cell adhesion, which do not exist
in SNU449 cells.
Lupane-derived triterpenoid compounds with a pentacyclic back-
bone like TA have been known for 20 years to have cytostatic activity
[29]. Dehydrothyrsiferol, a triterpenoid, was recently shown to mod-
ulate integrin afﬁnity without changing the expression of cell surface
integrin expression, FAK, or Akt phosphorylation levels, leading to
anoikis of human breast cancer cells [30]. TA is not soluble in water
or culture media but in DMSO and would not generally affect cell
adhesion property via its function as a detergent, since TA treatment
caused detachment-related death only of TM4SF5-expressing cells,
but not -null cells. Our observations with chemical derivatives of TA
suggest that a structural speciﬁcity of TA exists to inhibit proliferation
and survival of TM4SF5-positive cells, indicating that a COOH group at
C27 is important for the inhibitory effects on growth and survival ofTM4SF5-positive cells (in preparation). On the other hand, tetraspa-
nins or TM4SFs form massive complexes with integrins on the cell
surface to function in cell adhesion [28]. Although attempts to
coimmunoprecipitate TM4SF5 and integrin α5 in the absence of TA
treatment of SNU449Tp or T16 cells failed, the connection between
integrin and pY397FAK was disrupted by TA treatment. Therefore, TA
may interfere with the cross-talk between TM4SF5 and integrins, at
the level of effectors downstream of the receptors, which may be
important for regulation of focal adhesion assembly and cell–ECM
adhesion.
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